GGrantIndex
Sort

53,477 grants matching addiction

TREATMENT OF ADDICTIONS--BIOLOGICAL CORRELATES

$3,025,003
Rockefeller University · P60 · FY2005 · DA

A novel and highly selective orexin 1 receptor antagonist for the treatment of patients with opioid use disorder.

$3,024,162
Ian Gurrell · Astrazeneca Pharmaceuticals, Lp · UH3 · FY2024 · DA

Neural circuit dynamics of drug action

$3,017,179
Karl Alexander Deisseroth · Stanford University · P50 · FY2020 · DA

Clinical Evaluation of C4X3256, a Non-Opioid, Highly-Selective Orexin-1 Receptor Antagonist for the Treatment of Opioid Use Disorder

$3,016,228
Christian Arthur Heidbreder · Indivior, Inc. · UG3 · FY2019 · DA

Development of MRI Techniques for Drug-Abuse Applications

$3,014,729
Yihong Yang · National Institute On Drug Abuse · Z01 · FY2008 · DA

Characterization of neuronal ensembles activated during cue-induced reward seeking

$3,014,162
Bruce Hope · National Institute On Drug Abuse · ZIA · FY2025 · DA

Clinical Genomics and Experimental Therapeutics

$3,010,409
Falk Lohoff · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2015 · AA

Center for Genetic Studies of Drug Abuse in Outbred Rats

$3,009,655
Abraham A Palmer · University Of California, San Diego · P50 · FY2021 · DA

Basic and Translational Research Center for Reducing Health Disparities

$3,007,552
Robert P Dottin · Hunter College · G12 · FY2011 · RR

NIDA Clinical Trials Network: Greater New York Node

$3,006,654
John P Rotrosen · New York University School Of Medicine · UG1 · FY2016 · DA

TREATMENT OF ADDICTIONS-BIOLOGICAL CORRELATES

$3,004,908
Mary J Kreek · Rockefeller University · P60 · FY2009 · DA

Helping to End Addiction Long-term (HEAL): Probe/Drug Lead Production

$3,002,829
Matthew Hall · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR

Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)

$3,001,225
Lorenzo Leggio · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2015 · AA

The Y-SCORCH Data Generation Center at Yale for Single-Cell Opioid Responses in the Context of HIV

$3,000,000
Serena S Spudich · Yale University · UM1 · FY2021 · DA

The Y-SCORCH Data Generation Center at Yale for Single-Cell Opioid Responses in the Context of HIV

$3,000,000
Serena S Spudich · Yale University · UM1 · FY2020 · DA

The Y-SCORCH Data Generation Center at Yale for Single-Cell Opioid Responses in the Context of HIV

$3,000,000
Serena S Spudich · Yale University · UM1 · FY2025 · DA

The Y-SCORCH Data Generation Center at Yale for Single-Cell Opioid Responses in the Context of HIV

$3,000,000
Serena S Spudich · Yale University · UM1 · FY2022 · DA

The Y-SCORCH Data Generation Center at Yale for Single-Cell Opioid Responses in the Context of HIV

$3,000,000
Serena S Spudich · Yale University · UM1 · FY2023 · DA

Neural circuit dynamics of drug action

$2,999,286
Karl Alexander Deisseroth · Stanford University · P50 · FY2021 · DA

Novel Medication Approaches for Substance Abuse

$2,998,246
Herbert David Kleber · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · P50 · FY2008 · DA

Development of a Next Generation Vaccine for Smoking Cessation and Relapse Preven

$2,996,608
Lloyd Patrick Johnston · Selecta Biosciences, Inc. · RC3 · FY2010 · DA

CONSTRUCTION OF ADDICTION RESEARCH CENTEr

$2,996,175
University Of Texas Hlth Sci Ctr San Ant · C06 · FY2002 · RR

JCOIN Coordination and Translation Center

$2,991,875
Faye S Taxman · George Mason University · U2C · FY2021 · DA

Center for Neural Circuits in Addiction

$2,989,325
Mark J Thomas · University Of Minnesota · P30 · FY2025 · DA

Center for Genetic Studies of Drug Abuse in Outbred Rats

$2,989,274
Abraham A Palmer · University Of California, San Diego · P50 · FY2022 · DA